Because survodutide is earlier in its trial lifecycle, its longer-term safety data is less complete than tirzepatides, which has accumulated monitoring data across a larger number of study participants and a longer observation window
It is hypothesized that the slowing of gastric emptying contributes to some of the more common adverse events that occur with tirzepatide and selective GLP-1RAs (e.g., nausea, diarrhea, and vomiting), as the incidence of these events most commonly coincides with the timing of the early gastric slowing
To make matters worse, chronic diseases (e.g., type 2 diabetes and heart disease ) can deplete GSH levels, making bodily cells more prone to oxidative stress, or cell damage ( 1 , 2 , 7 )
It was identified, isolated, and characterized by a research group at the University of Zagreb led by Predrag Sikiric, who has been the central figure in the BPC-157 literature for more than two decades
DPP-4 inhibitors and lipids: systematic review and meta-analysis
Furanodienone induces G0/G1 arrest and causes apoptosis via the ROS/MAPKs-mediated caspase-dependent pathway in human colorectal cancer cells: a study in vitro and in vivo